Delivery Order SPE2DB20D2104-SPE2DB24FR27B

Award Date 11/21/23
Potential Completion Date 11/22/23
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ROTARIX vaccine oral syringes, 1.5 mL, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $1,464.78, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 13, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with...
This federal contract award is for the delivery of ROTARIX vaccine oral syringes (1.5 ml) to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $8,909.40. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award is for the delivery of the ROTARIX vaccine oral syringes (1.5ml) to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $9,037.10. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award is for the delivery of the ROTARIX vaccine oral syringes (1.5 ml) to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $5,126.04, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop...
This federal contract award is for the delivery of ROTARIX vaccine oral syringes (1.5 mL) to the Defense Logistics Agency (DLA). The contract, valued at $7,420.77, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award is for the delivery of the ROTARIX vaccine oral syringe 1.5 mL to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $50,253.00, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 through 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of ROTARIX VACCINE ORAL SYRINGE 1.5ML to the Defense Logistics Agency (DLA). The award, valued at $5,570.55, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products...
This federal contract award is for the delivery of Rotarix vaccine oral syringes (1.5 mL) to the Defense Logistics Agency (DLA). The $3,302.40 firm fixed price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 28, 2023 and was awarded on August 25, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the ROTARIX vaccine oral syringe 1.5ML. The $2,929.56 firm fixed-price contract has an ultimate completion date of October 22, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the ROTARIX VACCINE ORAL SYRINGE 1.5ML to the Defense Logistics Agency (DLA). The $9,609.02 firm fixed-price delivery order has a completion date of June 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables efficient...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FR27B
    Delivery Order

This federal contract award is for the delivery of ROTARIX oral vaccine syringes (1.5 ml) to the Defense Logistics Agency (DLA). The $2,001.24 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999. This IDC serves as a primary vehicle for AmerisourceBergen to provide a broad range of pharmaceutical products and medical supplies, including specialty medications, generic drugs, and vaccines, to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award is part of the DLA's efforts to ensure the availability of critical medical commodities for military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 2/27/25, 11:00 AM